Clinical trials
Withdrawn Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2012 | 1 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| City of Hope Medical Center | 2 |
| Northwestern University | 2 |
| Ascentage Pharma Group Inc. | 1 |
| Baxalta now part of Shire | 1 |
| Case Comprehensive Cancer Center | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Hadassah Medical Organization | 1 |
| Keros Therapeutics, Inc. | 1 |
| Lynk Pharmaceuticals Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 28 |
| Myeloproliferative Disorders | 16 |
| Leukemia, Myeloid, Acute | 12 |
| Myelodysplastic Syndromes | 12 |
| Polycythemia Vera | 12 |
| Leukemia, Myelomonocytic, Chronic | 11 |
| Lymphoma, Non-Hodgkin | 11 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Lymphoma, Follicular | 10 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 10 |
Trials
Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.